NovoTTF-200A (Optune)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NovoTTF-200A (Optune), covering 2024-11-18 to 2024-11-18. Get the full timeline:
Most recent: Clinical Trial Update: NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma [Phase 1]